Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326:1457-1458 (28 June), doi:10.1136/bmj.326.7404.1457-c
| The first 150 words of the full text of this article appear below. |
EDITORSwensen in his editorial discusses the effect of false positive diagnoses and excessive costs of screening.1 He describes 700 ancillary findings in a screening study of computed tomography of the body, in which most of these ancillary findings were falsely positive and whose investigation adversely affected quality of life and resulted in unnecessary diagnostic and interventional procedures.
In two tier healthcare systems where public and private facilities run side
by side the unnecessary diagnostic and interventional procedures referred to
by Swenson will tend to be devolved to the public sector. In my (public)
hospital we regularly receive requests for follow up computed tomography
scanning on the basis of findings detected at local private screening
facilities. The patient, having paid several hundred dollars to find out he or
she has a 4 mm lung nodule, rightly or wrongly expects that the healthcare
system will now take him or her
Andrew C Mason, consultant radiologist
Ridge Meadows Hospital, Maple Ridge, BC, Canada V2X 7G5 andrew.mason@fraserhealth.ca